Biotechnology Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1785 | QURE uniQure N.V. - Ordinary Shares | 43.35 USD | +4.68% | -7.41% | +58.62% | +198.97% | 2.73 B USD | ||
| 1786 | TRVI Trevi Therapeutics, Inc. - Common Stock | 18.27 USD | -6.31% | +1.61% | +33.85% | +206.03% | 2.59 B USD | ||
| 1790 | IMNM Immunome, Inc. - Common Stock | 24.04 USD | -1.44% | +12.71% | +27.13% | +177.92% | 2.72 B USD | ||
| 1795 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.65 USD | -3.09% | +10.02% | +25.00% | +19.39% | 2.71 B USD | ||
| 1830 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 42.90 USD | -2.52% | +13.25% | +55.10% | -1.13% | 2.55 B USD | ||
| 1842 | NKTR Nektar Therapeutics - Common Stock | 71.91 USD | -3.99% | +7.91% | +26.16% | -1.86% | 2.43 B USD | ||
| 1845 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.51 USD | -3.65% | -4.04% | +45.48% | +109.72% | 2.43 B USD | ||
| 1849 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 29.68 USD | -2.56% | +8.12% | +29.66% | -26.48% | 2.45 B USD | ||
| 1873 | VCEL Vericel Corporation - Common Stock | 46.46 USD | -1.04% | +3.50% | +26.70% | +27.81% | 2.37 B USD | ||
| 1874 | KOD Kodiak Sciences Inc - Common Stock | 38.42 USD | +0.31% | +1.35% | +27.68% | +867.76% | 2.40 B USD | ||
| 1878 | NTLA Intellia Therapeutics, Inc. - Common Stock | 16.41 USD | -5.85% | -6.39% | +19.17% | +19.61% | 2.29 B USD | ||
| 1882 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.72 USD | -5.78% | -3.71% | +59.00% | +505.71% | 2.37 B USD | ||
| 1889 | BHVN Biohaven Ltd. Common Shares | 15.48 USD | -0.39% | +4.03% | +38.21% | -8.62% | 2.33 B USD | ||
| 1911 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.98 USD | -3.39% | +1.63% | +20.53% | -13.22% | 2.19 B USD | ||
| 1914 | PHVS Pharvaris N.V. - Ordinary Shares | 34.23 USD | -1.04% | +0.94% | +8.15% | +90.48% | 2.23 B USD | ||
| 1922 | ZLAB Zai Lab Limited - American Depositary Shares | 18.97 USD | -1.96% | -2.87% | +15.11% | -28.92% | 2.13 B USD | ||
| 1927 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 37.57 USD | -1.80% | +3.44% | +14.68% | +21.59% | 2.18 B USD | ||
| 1932 | ABCL AbCellera Biologics Inc. - Common Shares | 7.15 USD | -7.02% | -3.25% | +27.91% | +80.10% | 2.18 B USD | ||
| 1945 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 24.11 USD | +3.74% | +14.59% | +39.36% | +173.05% | 2.14 B USD | ||
| 1949 | ADMA ADMA Biologics Inc - Common Stock | 9.20 USD | -0.11% | +5.63% | +13.72% | -49.31% | 2.13 B USD |
News Biotechnology Stocks
Chemomab Therapeutics Ltd. (CMMB) M&A Call Prepared Remarks Transcript
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts
CytomX Therapeutics (CTMX) Upgraded to Buy: Here's Why
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy
PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should Know
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |